ENDPOINTS NEWS26 天
Synaf­fix adds Boehringer and Mit­subishi Tan­abe as ADC li­cens­ing part­ners
Lon­za’s Synaf­fix has se­cured two sep­a­rate li­cens­ing deals with Boehringer In­gel­heim and Japan­ese drug­mak­er Mit­subishi Tan­abe Phar­ma for its an­ti­body-drug con ...
FierceBiotech26 天
Lonza's Synaffix adds Boehringer to its constellation of partners with $1.3B ADC tech pact
After inking a series of partnerships late last year, Lonza’s antibody-drug conjugate (ADC) specialist Synaffix is kicking off 2025 with a return to the dealmaking table. Under a new licensing ...